Pembrolizumab-Induced Hypophysitis With Isolated Adrenocorticotropic Hormone (ACTH) Deficiency: A Rare Immune-Mediated Adverse Event

Pembrolizumab is an immune checkpoint inhibitor that targets the programmed cell death protein 1 antigen to stimulate an immune response against tumor cells. It has successfully induced remission in patients with severe metastatic disease, including those refractory to other chemotherapeutic regimen...

Descripción completa

Detalles Bibliográficos
Autores principales: Doodnauth, Andrew V, Klar, Miriam, Mulatu, Yohannes S, Malik, Zohra R, Patel, Krunal H, McFarlane, Samy I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186842/
https://www.ncbi.nlm.nih.gov/pubmed/34123679
http://dx.doi.org/10.7759/cureus.15465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186842/
https://www.ncbi.nlm.nih.gov/pubmed/34123679
http://dx.doi.org/10.7759/cureus.15465

Ejemplares similares